An Interventional, Placebo-Controlled, Randomized, Double-blinded Dose Comparison, Phase I Study to Determine the Safety and; Efficacy of a New Gel Formulation of Esmolol Hydrochloride (Galnobax) for the Treatment of Diabetic Foot Ulcer (DFU).
Phase of Trial: Phase I/II
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Esmolol (Primary)
- Indications Diabetic foot ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors NovaLead Pharma Pvt. Ltd
- 27 Jan 2016 Status changed from active, no longer recruiting to completed, as reported on the company pipeline.
- 26 Sep 2013 New source identified and integrated (Clinical Trials Registry - India: CTRI2013-07-003838).
- 05 May 2010 New trial record